XML 27 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Capital Stock, Warrants and Stock Options
12 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Note 6 - Capital Stock, Warrants and Stock Options

Authorized

 

The total authorized capital is as follows:

 

  - 300,000,000 common shares with a par value of $0.001 per common share; and
     
  - 10,000,000 preferred shares with a par value of $0.001 per preferred share

 

Issued and outstanding

 

On September 30, 2014, the Company issued 34,889 common shares to employees of the Company, at a price of $7.50 per share, in settlement of arrears compensation obligations of $261,665.

 

On October 17, 2014, the Company issued 6,659,487 common shares, at a price of $0.1875 per share, in settlement of a secured loan facility, which included any unpaid and accrued interest, totaling $1,248,654. In conjunction with the issuance of these common shares, the Company incurred $40,400 in share issuance costs.

 

On December 31, 2014, the Company issued 11,333 common shares to employees of the Company, at a price of $7.50 per share, in settlement of arrears compensation obligations of $85,000.

 

For the above share issuances, the shares were not registered under the Securities Act of 1933 in reliance upon the exemptions from registration contained in Regulation S of the Securities Act of 1933. No underwriters were used, nor were any brokerage commissions paid in connection with the above share issuances.

 

Warrants

 

As at June 30, 2016, the aggregate weighted average intrinsic value of 13,333 warrants outstanding was $0, and the weighted average grant date fair value of each warrant outstanding was CAD $11.25. The 13,333 warrants expired on August 4, 2016.

 

Stock Options

 

On November 14, 2014, the vested and non-vested portion of the 400,000 stock options granted to purchase common shares by directors, officers and employees were cancelled or forfeited.

 

On February 17, 2015, the Company granted a total of 1,182,667 stock options to purchase common shares to directors, officers and an employee of the Company, at an exercise price of $0.1875 per share and for a term of 5 years.

   

Stock based compensation expense, resulting from the vesting of stock options for the year ended June 30, 2016 was $60,961 (2015 - $162,794), which is included in operation and administration expense on the statements of operations and comprehensive loss.

 

The fair value of stock options was determined on the date of grant using the Black-Scholes valuation model, and using the following underlying assumptions:

 

Year   Risk free
interest rate
    Dividend
yield
    Volatility     Weighted
average life
 
                           
2015   1.62% – 2.09 %     0 %   125.00% - 127.32 %   5 years  

 

The following table summarizes the stock option activity during the period being reported on and ending June 30, 2016:

 

Description   Options     Weighted
average
exercise
price ($)
 
Outstanding, July 1, 2014     446,667       3.75  
Granted     1,182,667       0.1875  
Exercised     -       -  
Expired or forfeited     400,000       2.80  
Outstanding, June 30, 2015     1,229,334       0.61  
Exercisable, June 30, 2015     440,889       1.36  
                 
Outstanding, July 1, 2015     1,229,334       0.61  
Granted     -       -  
Exercised     -       -  
Expired or forfeited     46,667       11.25  
Outstanding, June 30, 2016     1,182,667       0.1875  
Exercisable, June 30, 2016     1,182,667       0.1875  

 

The following table summarizes the information on stock options outstanding at June 30, 2016:

 

Stock options outstanding     Stock options exercisable  
Exercise
prices
    Number of
options
    Weighted
average
exercise price
    Weighted
average
remaining
life in years
    Number of
options
    Weighted
average
exercise price
 
                                             
$ 0.1875       1,182,667     $ 0.1875       3.64       1,182,667     $ 0.1875  

 

As at June 30, 2016 there were 1,182,667 stock options outstanding, exercisable at a weighted average exercise price of $0.1875 per share, and expiring on February 17, 2020.